Article Versions Notes

Lin P-Y, Zeng B-Y, Hsu C-W, Suen M-W, Hung C-M, Stubbs B, Chen Y-W, Chen T-Y, Lei W-T, Chen J-J, et al. Divergent Risks of Hematologic Malignancies Associated with GLP-1 Receptor Agonists and SGLT2 Inhibitors: Preliminary Findings from a Pilot Network Meta-Analysis. Biomolecules. 2025; 15(11):1622. https://doi.org/10.3390/biom15111622

Lin, Pao-Yen, Bing-Yan Zeng, Chih-Wei Hsu, Mein-Woei Suen, Chao-Ming Hung, Brendon Stubbs, Yen-Wen Chen, Tien-Yu Chen, Wei-Te Lei, Jiann-Jy Chen, and et al. 2025. "Divergent Risks of Hematologic Malignancies Associated with GLP-1 Receptor Agonists and SGLT2 Inhibitors: Preliminary Findings from a Pilot Network Meta-Analysis" Biomolecules 15, no. 11: 1622. https://doi.org/10.3390/biom15111622

Lin, P.-Y., Zeng, B.-Y., Hsu, C.-W., Suen, M.-W., Hung, C.-M., Stubbs, B., Chen, Y.-W., Chen, T.-Y., Lei, W.-T., Chen, J.-J., Zeng, B.-S., Su, K.-P., Liang, C.-S., & Tseng, P.-T. (2025). Divergent Risks of Hematologic Malignancies Associated with GLP-1 Receptor Agonists and SGLT2 Inhibitors: Preliminary Findings from a Pilot Network Meta-Analysis. Biomolecules, 15(11), 1622. https://doi.org/10.3390/biom15111622